Lupin Looks To Next Generation In Narcolepsy With Tentative US Xywav Nod
Indian Firm Also Eligible To Move On First-Generation Xyrem – But Has Not Done So
Lupin may enjoy 180 days of market exclusivity for its proposed generic to Jazz’s next-generation Xywav treatment for sleep disorders.
